Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand
DarioHealth expanded its cardiometabolic platform with the launch of Dario Women and Dario Sleep, two new solutions targeting perimenopause and obstructive sleep apnea. The programs are expected to roll out to Fortune 500 clients in Fall 2026, with recurring revenue from the digital platform anticipated in Q4 2026 and provider service revenue starting late 2026.
Key figures
- Digital revenue start
- Q4 2026
- Provider services revenue start
- end of 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.